Evidence map›Paper›PMID 34090140›Full record

ArticlePsychoneuroendocrinology2021

Distress Trajectories in Black and White Breast Cancer Survivors: From Diagnosis to Survivorship.

Annelise A Madison, Juan Peng, M Rosie Shrout, Megan E Renna, Catherine M Alfano, Stephen P Povoski, Adele M Lipari, Doreen M Agnese, William E Carson, William B Malarkey and 1 more

Open access · greenAbstract read
In one paragraph

Article in Psychoneuroendocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Racial Differences in Breast Cancer Therapeutic Toxicity: Implications for Practice.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Annelise A MadisonInstitute for Behavioral Medicine Research, The Ohio State University College of Medicine, USA; Department of Psychology, The Ohio State University, USA. Electronic address: madison.119@osu.edu.
Juan PengCenter for Biostatistics, The Ohio State University, USA.
M Rosie ShroutInstitute for Behavioral Medicine Research, The Ohio State University College of Medicine, USA.
Megan E RennaInstitute for Behavioral Medicine Research, The Ohio State University College of Medicine, USA; Comprehensive Cancer Center, The Ohio State University, USA.
Catherine M AlfanoNorthwell Health Cancer Institute, USA.
Stephen P PovoskiComprehensive Cancer Center, The Ohio State University, USA.
Adele M LipariComprehensive Cancer Center, The Ohio State University, USA.
Doreen M AgneseComprehensive Cancer Center, The Ohio State University, USA.
William E CarsonComprehensive Cancer Center, The Ohio State University, USA.
William B MalarkeyInstitute for Behavioral Medicine Research, The Ohio State University College of Medicine, USA; Department of Internal Medicine, The Ohio State University College of Medicine, USA.
Janice K Kiecolt-GlaserInstitute for Behavioral Medicine Research, The Ohio State University College of Medicine, USA; Department of Psychiatry and Behavioral Health, The Ohio State University College of Medicine, USA.
The Ohio State University · USInstitute for Behavioral Medicine · US

Funding

The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve HealthUL1TR002733 · NCATS · OHIO STATE UNIVERSITY · PI RINGEL, MATTHEW D · 2018 to 2022
$28.9M
Breast Cancer Survivors Cardiovascular Risks: Treatment and Behavioral InfluencesR01CA186720 · NCI · OHIO STATE UNIVERSITY · PI KIECOLT-GLASER, JANICE · 2014 to 2018
$4.6M
Fatigue, Depression, and Inflammation in Cancer Survivors: A Prospective StudyR01CA131029 · NCI · OHIO STATE UNIVERSITY · PI KIECOLT-GLASER, JANICE · 2008 to 2013
$4.1M
NRSA Training CoreTL1TR002735 · NCATS · OHIO STATE UNIVERSITY · PI BUMGARDNER, GINNY L, KIRSCHNER, LAWRENCE S · 2018 to 2022
$1.3M
NCATS NIH HHS TL1 TR002735NCATS NIH HHS UL1 TR002733NCI NIH HHS R01 CA131029NCI NIH HHS R01 CA186720
6 · The paper itself

Abstract

backgroundBlack breast cancer survivors have greater morbidity and mortality than White survivors. However, evidence comparing Black survivors' psychological symptoms with their White counterparts has been mixed. Prior studies have not compared Black and White survivor's distress-related symptom trajectories from pre- to post-treatment - the goal of the current study.

methodsAt three annual visits from shortly after diagnosis to 6 and 18 months post-treatment, 195 women (n = 163 White; n = 32 Black) reported their cancer-related distress (intrusive thoughts and avoidance), perceived stress, anxiety and depressive symptoms, fatigue, and pain.

resultsAdjusting for age, educational attainment, income, treatment type, stage at diagnosis, and physical comorbidities, Black and White breast cancer survivors had different trajectories of cancer-related distress (p = .004), intrusive thoughts about cancer diagnosis and treatment (p = .002), perceived stress (p = .04), emotional fatigue (p = .01), and vigor (p = .02). Specifically, among White women, these distress-related symptoms improved from diagnosis to 6 months post-treatment (ps < 0.0001) and then remained stable between 6 and 18 months post-treatment, whereas Black women had persistently elevated distress - even 18 months after finishing treatment. Additionally, Black women reported more avoidance of cancer-related thoughts and emotions across visits (p = .047). Race was unrelated to the trajectories of anxiety and depressive symptoms, other fatigue subscales, or pain levels (ps > 0.08).

conclusionLongitudinal assessment of the same breast cancer survivors from diagnosis to early survivorship revealed that Black and White survivors had divergent trajectories of psychological distress symptoms that were not reliably evident at a single timepoint. Overall, White women reported less psychological distress from pre- to post-treatment, but Black women's distress remained high from diagnosis to 18 months post-treatment. If left untreated, Black women's high distress levels may contribute to their poorer health throughout survivorship.

Indexed as

Black PeopleBreast NeoplasmsCancer SurvivorsPsychological DistressWhite PeopleFemaleHumansSurvivorshipBreast cancerDistressHealth disparitiesRace

Identifiers

PMID34090140
PMCPMC8405565
OpenAlexW3168214050

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.